An interactive algorithm for the assessment of cumulative cortisol suppression during inhaled corticosteroid therapy

AAPS PharmSci

Volumn 2, Issue 3, 2000, Pages 28-37

  Krishnaswami, Sriram ^a   Hochhaus, Guenther ^a   Derendorf, Hartmut ^a  

^a UNIVERSITY OF FLORIDA HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33947271457     PISSN: 15221059     EISSN: None     Source Type: Journal    
DOI: 10.1208/ps020322     Document Type: Article

References (15)

1. Lipworth BJ. Systemic adverse effects of inhaled corticosteroid therapy: A systematic review and meta-analysis. Arch Intern Med. 1999;159:941-955.
2. Chrousos GP, Harris AG. Hypothalamic-pituitary-adrenal axis suppression and inhaled corticosteroid therapy. 2. Review of the literature. Neuroimmunomodulation. 1998;5:288-308.
3. Chrousos GP, Harris AG. Hypothalamic-pituitary-adrenal axis suppression and inhaled corticosteroid therapy. 1. General principles. Neuroimmunomodulation. 1998;5:277-287.
4. Rohatagi S, Bye A, Falcoz C, Mackie AE, Meibohm B, Mollmann H, Derendorf H. Dynamic modeling of cortisol reduction after inhaled administration of fluticasone propionate. J Clin Pharmacol. 1996;36:938-941.
5. Rohatagi S, Tauber U, Richter K, Derendorf H. Pharmacokinetic/pharmacodynamic modeling of cortisol suppression after oral administration of fluocortolone. J Clin Pharmacol. 1996;36:311-314.
6. Rohatagi S, Hochhaus G, Mollmann H, et al. Pharmacokinetic and pharmacodynamic evaluation of triamcinolone acetonide after intravenous, oral, and inhaled administration. J Clin Pharmacol. 1995;35:1187-1193.
7. Rohatagi S, Bye A, Mackie A, Derendorf H. Mathematical modeling of cortisol circadian rhythm and cortisol suppression. Eur J Pharm Sci. 1996;4:341-350.
8. Koopmans RP, Braat MC, Oosterhuis B, van Boxtel CJ. Time-dependent effects of dexamethasone administration on the suppression of plasma hydrocortisone, assessed with a pharmacokinetic model. J Pharmacol Exp Ther. 1992;262:503-508.
9. Kong AN, Ludwig EA, Slaughter RL, et al. Pharmacokinetics and pharmacodynamic modeling of direct suppression effects of methylprednisolone on serum cortisol and blood histamine in human subjects. Clin Pharmacol Ther. 1989;46:616-628.
10. Chakraborty A, Krzyzanski W, Jusko WJ. Mathematical modeling of circadian cortisol concentrations using indirect response models: comparison of several methods. J Pharmacokinet Biopharm. 1999;27:23-43.
11. Meibohm B, Hochhaus G, Mollmann H, et al. A pharmacokinetic/pharmacodynamic approach to predict the cumulative cortisol suppression of inhaled corticosteroids. J Pharmacokinet Biopharm. 1999;27:127-147.
12. Meibohm B, Hochhaus G, Rohatagi S, et al. Dependency of cortisol suppression on the administration time of inhaled corticosteroids [published erratum appears in J Clin Pharmacol 1997 Nov;37(11):1000]. J Clin Pharmacol. 1997;37:704-710.
13. Lonnebo A, Grahnen A, Jansson B, Brundin RM, Ling-Andersson A, Eckernas SA. An assessment of the systemic effects of single and repeated doses of inhaled fluticasone propionate and inhaled budesonide in healthy volunteers. Eur J Clin Pharmacol. 1996;49:459-463.
14. Grahnen A, Eckernas SA, Brundin RM, Ling-Andersson A. An assessment of the systemic activity of single doses of inhaled fluticasone propionate in healthy volunteers [see comments]. Br J Clin Pharmacol. 1994;38:521-525.
15. Derom E, Van Schoor J, Verhaeghe W, Vincken W, Pauwels R. Systemic effects of inhaled fluticasone propionate and budesonide in adult patients with asthma. Am J Respir Crit Care Med. 1999;160:157-161.